-
PurposeBioluminescent Reporter of Intracellular Calcium
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 83926 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepRSETb
-
Backbone manufacturerInvitrogen
- Backbone size w/o insert (bp) 2787
- Total vector size (bp) 4224
-
Modifications to backboneThe T7-tag, Xpress tag and Multiple Cloning Site of pRSETb was removed via restriction digestion of the NheI and HindIII sites. An EcoRI site was inserted downstream of the new NheI site, and CalfluxVTN was inserted via the new EcoRI and HindIII restriction sites.
-
Vector typeBacterial Expression
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberUnknown
Gene/Insert
-
Gene/Insert nameCalfluxVTN
-
Alt nameVenus-TnC-NanoLuc
-
SpeciesSynthetic
-
Insert Size (bp)1437
-
MutationNone
-
GenBank ID
- Promoter T7
Cloning Information
- Cloning method Restriction Enzyme
- 5′ cloning site EcoRI (not destroyed)
- 3′ cloning site HindIII (not destroyed)
- 5′ sequencing primer T7 promoter
- 3′ sequencing primer T7 terminator (Common Sequencing Primers)
Resource Information
-
Articles Citing this Plasmid
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pT7-CalfluxVTN was a gift from Carl Johnson (Addgene plasmid # 83926 ; http://n2t.net/addgene:83926 ; RRID:Addgene_83926) -
For your References section:
Coupling optogenetic stimulation with NanoLuc-based luminescence (BRET) Ca++ sensing. Yang J, Cumberbatch D, Centanni S, Shi SQ, Winder D, Webb D, Johnson CH. Nat Commun. 2016 Oct 27;7:13268. doi: 10.1038/ncomms13268. 10.1038/ncomms13268 PubMed 27786307